- Home
- MCW vs HRMY Comparison
MCW vs HRMY Comparison
Compare MCW & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCW | HRMY |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MCW | HRMY |
|---|---|---|
| Price | $7.03 | $30.81 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $7.28 | ★ $44.11 |
| AVG Volume (30 Days) | ★ 2.4M | 814.5K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.62 | 7.97 |
| EPS | 0.31 | ★ 2.71 |
| Revenue | ★ $1,051,731,000.00 | $868,453,000.00 |
| Revenue This Year | $7.92 | $19.75 |
| Revenue Next Year | $7.05 | $12.88 |
| P/E Ratio | $22.60 | ★ $11.82 |
| Revenue Growth | 5.73 | ★ 21.51 |
| 52 Week Low | $4.61 | $25.52 |
| 52 Week High | $7.81 | $40.87 |
Technical Indicators
Market Signals| Indicator | MCW | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 63.45 | 59.55 |
| Support Level | $6.95 | $25.92 |
| Resistance Level | $7.13 | $38.65 |
| Average True Range (ATR) | 0.02 | 1.28 |
| MACD | -0.01 | 0.44 |
| Stochastic Oscillator | 92.86 | 49.61 |
Price Performance
Historical ComparisonAbout MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.